ArticleBioscience reports2021

Combined bezafibrate, medroxyprogesterone acetate and valproic acid treatment inhibits osteosarcoma cell growth without adversely affecting normal mesenchymal stem cells.

Jonathan J Sheard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.